TORRENT PHARMACEUTICALS LTD. has reported financial results for the period ended June 30, 2021.
Financial Results (Q1 FY 2021-22) - QoQ Comparison
The company has reported total income of Rs.2174 crores during the period ended June 30, 2021 as compared to Rs.1976 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.330 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.324 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.19.53 for the period ended June 30, 2021 as compared to Rs.19.16 for the period ended March 31, 2021.
|
Total Income | ₹ 2174 crs | ₹ 1976 crs | 10.02% |
Net Profit | ₹ 330 crs | ₹ 324 crs | 1.85% |
EPS | ₹ 19.53 | ₹ 19.16 | 1.93% |
Financial Results (Q1 FY 2021-22) - YoY ComparisonThe company has reported total income of Rs.2174 crores during the period ended June 30, 2021 as compared to Rs.2060 crores during the period ended June 30, 2020.
The company has posted net profit / (loss) of Rs.330 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.321 crores for the period ended June 30, 2020.
The company has reported EPS of Rs.19.53 for the period ended June 30, 2021 as compared to Rs.18.98 for the period ended June 30, 2020.
|
Total Income | ₹ 2174 crs | ₹ 2060 crs | 5.53% |
Net Profit | ₹ 330 crs | ₹ 321 crs | 2.8% |
EPS | ₹ 19.53 | ₹ 18.98 | 2.9% |
Shares of TORRENT PHARMACEUTICALS LTD. was last trading in BSE at Rs. 3003.75 as compared to the previous close of Rs. 3079.05. The total number of shares traded during the day was 10780 in over 2910 trades.
The stock hit an intraday high of Rs. 3121.45 and intraday low of 2966.9. The net turnover during the day was Rs. 32891177.
Source : Equity Bulls
Keywords